Latest News about LLY
Recent news which mentions LLY
These 5 Wildly Popular High-Flying Stocks of 2023 Could Be Duds in the Rest of 2024, According to Wall Street
January 22, 2024
From Motley Fool
Prediction: This Will Be the First Trillion-Dollar Healthcare Stock
January 21, 2024
Tickers
LLY
From Motley Fool
24 Dividend Growth Stocks to Buy and Hold in 2024
January 21, 2024
From Motley Fool
Here's What Investors Should Expect From Eli Lilly Stock in 2024
January 20, 2024
Tickers
LLY
From Motley Fool
Will Eli Lilly Be Worth More Than Meta Platforms by 2030?
January 20, 2024
From Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
From Motley Fool
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
January 19, 2024
From Benzinga
From Benzinga
Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?
January 18, 2024
From Benzinga
From Benzinga
Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost
January 17, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
From Benzinga
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
January 15, 2024
From Motley Fool
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
January 14, 2024
From Motley Fool
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
January 14, 2024
From Motley Fool
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
January 13, 2024
From Motley Fool
3 Unstoppable Stocks to Buy in 2024
January 13, 2024
From Motley Fool
Portfolio Protection: 7 Risky Stocks to Drop Right Now
January 12, 2024
From InvestorPlace
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
From Benzinga
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
January 11, 2024
From Benzinga
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
From InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
From Benzinga
Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?
January 11, 2024
From InvestorPlace
Why Eli Lilly Stock Skyrocketed 59% in 2023
January 11, 2024
From Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
January 10, 2024
Tickers
LLY
From Benzinga
Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy
January 10, 2024
From Benzinga
Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.
January 10, 2024
Tickers
LLY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.